A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

Lexapro is an antidepressant medication commonly prescribed for anxiety. Here's how to know the best time of day to take it.

Alto Neuroscience has reported positive outcomes from the interim analysis of its double-blind Phase IIb trial of oral ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

A recent study published in the Journal of Psychopharmacology has offered encouraging preliminary findings for individuals ...

Elon Musk was asked about his ketamine usage in an interview with Don Lemon. The head of DOGE says it's purely for medical ...

Study: Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled ... SSRIs are widely used antidepressants that are readily available and affordable ...

The U.S. Food and Drug Administration has approved Spravato ... who have had an inadequate response to at least two oral antidepressants, according to a news release issued by Johnson & Johnson.

(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at ...

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved ... not responded adequately to at least two oral antidepressants. The company hailed the approval as ...

Now, the Food and Drug Administration (FDA ... Meaning, there's no need to take an oral antidepressant with it. That said, Spravato is a tightly controlled medication, and getting it isn't ...

The approval, which followed FDA priority review of a supplemental new drug application submitted in July 2024, stemmed from results of a randomized, double-blind, multicenter, placebo-controlled ...